Fundamental Analysis of OBLONG INC(NASDAQ:OBLG) stock

Fundamental Rating

Taking everything into account, OBLG scores 2 out of 10 in our fundamental rating. OBLG was compared to 277 industry peers in the Software industry. While OBLG has a great health rating, there are worries on its profitability. OBLG is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year OBLG has reported negative net income.

In the past year OBLG has reported a negative cash flow from operations.

In the past 5 years OBLG always reported negative net income.

OBLG had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -91.69%, OBLG is doing worse than 90.55% of the companies in the same industry.

Looking at the Return On Equity, with a value of -122.73%, OBLG is doing worse than 76.73% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-91.69%
ROE	-122.73%
ROIC	N/A

ROA(3y)-166.17%

ROA(5y)-109.82%

ROE(3y)-249.25%

ROE(5y)-164.15%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 18.41%, OBLG is doing worse than 84.36% of the companies in the same industry.

OBLG's Gross Margin has declined in the last couple of years.

OBLG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	18.41%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-23.07%

GM growth 5Y-9.55%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OBLG does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OBLG has more shares outstanding

OBLG has more shares outstanding than it did 5 years ago.

OBLG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

OBLG has an Altman-Z score of -54.01. This is a bad value and indicates that OBLG is not financially healthy and even has some risk of bankruptcy.

OBLG has a Altman-Z score of -54.01. This is amonst the worse of the industry: OBLG underperforms 96.73% of its industry peers.

There is no outstanding debt for OBLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-54.01

ROIC/WACCN/A

WACC9.87%

2.3 Liquidity

A Current Ratio of 3.98 indicates that OBLG has no problem at all paying its short term obligations.

OBLG has a better Current ratio (3.98) than 82.18% of its industry peers.

OBLG has a Quick Ratio of 3.90. This indicates that OBLG is financially healthy and has no problem in meeting its short term obligations.

With an excellent Quick ratio value of 3.90, OBLG belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.98
Quick Ratio	3.9

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

OBLG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.33%, which is quite impressive.

Looking at the last year, OBLG shows a very negative growth in Revenue. The Revenue has decreased by -31.86% in the last year.

Measured over the past years, OBLG shows a very negative growth in Revenue. The Revenue has been decreasing by -21.23% on average per year.

EPS 1Y (TTM)86.33%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q88.52%

Revenue 1Y (TTM)-31.86%

Revenue growth 3Y-37.13%

Revenue growth 5Y-21.23%

Revenue growth Q2Q-39.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OBLG. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

OBLG does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OBLONG INC

NASDAQ:OBLG (5/20/2024, 7:00:02 PM)

Premarket: 0.1794 +0 (+0.56%)

0.1784

+0.02 (+9.45%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.98M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-91.69%
ROE	-122.73%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	18.41%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.57

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	3.98
Quick Ratio	3.9
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)86.33%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-31.86%

Revenue growth 3Y-37.13%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

OBLONG INC (OBLG)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens